CHELSEA BIRKEMEIER: Open Payments
NPI 1912589318 · MIAMISBURG, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$630 in 26 payments from 14 companies in 2025. Trend: 2023 $320 · 2024 $736 · 2025 $630
Food & beverage: $630
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $159 |
| Neurocrine BioSciences, Inc. | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Almatica Pharma LLC | 2 | $55 |
| Alkermes, Inc. | 2 | $50 |
| Supernus Pharmaceuticals, Inc. | 3 | $47 |
| ABBVIE INC. | 2 | $40 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $25 |
Products named: Auvelity, INGREZZA, CAPLYTA, LOREEV XR, Qelbree, VRAYLAR, Jornay PM, VIVITROL.
Industry payments across OH — which companies pay providers there.
